Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma

IntroductionThe molecular subtype plays a significant role in breast carcinoma (BC), which is the main indicator to guide treatment and is closely associated with prognosis. The aim of this study was to investigate the feasibility and efficacy of an ultrasound-based radiomics nomogram in preoperativ...

Full description

Bibliographic Details
Main Authors: Jiangfeng Wu, Lifang Ge, Yun Jin, Yunlai Wang, Liyan Hu, Dong Xu, Zhengping Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.993466/full
_version_ 1798015939593109504
author Jiangfeng Wu
Lifang Ge
Yun Jin
Yunlai Wang
Liyan Hu
Dong Xu
Dong Xu
Zhengping Wang
author_facet Jiangfeng Wu
Lifang Ge
Yun Jin
Yunlai Wang
Liyan Hu
Dong Xu
Dong Xu
Zhengping Wang
author_sort Jiangfeng Wu
collection DOAJ
description IntroductionThe molecular subtype plays a significant role in breast carcinoma (BC), which is the main indicator to guide treatment and is closely associated with prognosis. The aim of this study was to investigate the feasibility and efficacy of an ultrasound-based radiomics nomogram in preoperatively discriminating the luminal from non-luminal type in patients with BC.MethodsA total of 264 BC patients who underwent routine ultrasound examination were enrolled in this study, of which 184 patients belonged to the training set and 80 patients to the test set. Breast tumors were delineated manually on the ultrasound images and then radiomics features were extracted. In the training set, the T test and least absolute shrinkage and selection operator (LASSO) were used for selecting features, and the radiomics score (Rad-score) for each patient was calculated. Based on the clinical risk features, Rad-score, and combined clinical risk features and Rad-score, three models were established, respectively. The performances of the models were validated with receiver operator characteristic (ROC) curve and decision curve analysis.ResultsIn all, 788 radiomics features per case were obtained from the ultrasound images. Through radiomics feature selection, 11 features were selected to constitute the Rad-score. The area under the ROC curve (AUC) of the Rad-score for predicting the luminal type was 0.828 in the training set and 0.786 in the test set. The nomogram comprising the Rad-score and US-reported tumor size showed AUCs of the training and test sets were 0.832 and 0.767, respectively, which were significantly higher than the AUCs of the clinical model in the training and test sets (0.691 and 0.526, respectively). However, there was no significant difference in predictive performance between the Rad-score and nomogram.ConclusionBoth the Rad-score and nomogram can be applied as useful, noninvasive tools for preoperatively discriminating the luminal from non-luminal type in patients with BC. Furthermore, this study might provide a novel technique to evaluate molecular subtypes of BC.
first_indexed 2024-04-11T15:42:44Z
format Article
id doaj.art-8ff408122abe489fb2387dac0d329025
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T15:42:44Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-8ff408122abe489fb2387dac0d3290252022-12-22T04:15:44ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.993466993466Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinomaJiangfeng Wu0Lifang Ge1Yun Jin2Yunlai Wang3Liyan Hu4Dong Xu5Dong Xu6Zhengping Wang7Department of Ultrasound, Dongyang People’s Hospital, Dongyang, Zhejiang, ChinaDepartment of Ultrasound, Dongyang People’s Hospital, Dongyang, Zhejiang, ChinaDepartment of Ultrasound, Dongyang People’s Hospital, Dongyang, Zhejiang, ChinaDepartment of Ultrasound, Dongyang People’s Hospital, Dongyang, Zhejiang, ChinaDepartment of Ultrasound, Dongyang People’s Hospital, Dongyang, Zhejiang, ChinaDepartment of Diagnostic Ultrasound Imaging and Interventional Therapy, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaInstitute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Ultrasound, Dongyang People’s Hospital, Dongyang, Zhejiang, ChinaIntroductionThe molecular subtype plays a significant role in breast carcinoma (BC), which is the main indicator to guide treatment and is closely associated with prognosis. The aim of this study was to investigate the feasibility and efficacy of an ultrasound-based radiomics nomogram in preoperatively discriminating the luminal from non-luminal type in patients with BC.MethodsA total of 264 BC patients who underwent routine ultrasound examination were enrolled in this study, of which 184 patients belonged to the training set and 80 patients to the test set. Breast tumors were delineated manually on the ultrasound images and then radiomics features were extracted. In the training set, the T test and least absolute shrinkage and selection operator (LASSO) were used for selecting features, and the radiomics score (Rad-score) for each patient was calculated. Based on the clinical risk features, Rad-score, and combined clinical risk features and Rad-score, three models were established, respectively. The performances of the models were validated with receiver operator characteristic (ROC) curve and decision curve analysis.ResultsIn all, 788 radiomics features per case were obtained from the ultrasound images. Through radiomics feature selection, 11 features were selected to constitute the Rad-score. The area under the ROC curve (AUC) of the Rad-score for predicting the luminal type was 0.828 in the training set and 0.786 in the test set. The nomogram comprising the Rad-score and US-reported tumor size showed AUCs of the training and test sets were 0.832 and 0.767, respectively, which were significantly higher than the AUCs of the clinical model in the training and test sets (0.691 and 0.526, respectively). However, there was no significant difference in predictive performance between the Rad-score and nomogram.ConclusionBoth the Rad-score and nomogram can be applied as useful, noninvasive tools for preoperatively discriminating the luminal from non-luminal type in patients with BC. Furthermore, this study might provide a novel technique to evaluate molecular subtypes of BC.https://www.frontiersin.org/articles/10.3389/fonc.2022.993466/fullultrasoundbreast carcinomaradiomicsnon-luminal typeluminal type
spellingShingle Jiangfeng Wu
Lifang Ge
Yun Jin
Yunlai Wang
Liyan Hu
Dong Xu
Dong Xu
Zhengping Wang
Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
Frontiers in Oncology
ultrasound
breast carcinoma
radiomics
non-luminal type
luminal type
title Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
title_full Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
title_fullStr Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
title_full_unstemmed Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
title_short Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
title_sort development and validation of an ultrasound based radiomics nomogram for predicting the luminal from non luminal type in patients with breast carcinoma
topic ultrasound
breast carcinoma
radiomics
non-luminal type
luminal type
url https://www.frontiersin.org/articles/10.3389/fonc.2022.993466/full
work_keys_str_mv AT jiangfengwu developmentandvalidationofanultrasoundbasedradiomicsnomogramforpredictingtheluminalfromnonluminaltypeinpatientswithbreastcarcinoma
AT lifangge developmentandvalidationofanultrasoundbasedradiomicsnomogramforpredictingtheluminalfromnonluminaltypeinpatientswithbreastcarcinoma
AT yunjin developmentandvalidationofanultrasoundbasedradiomicsnomogramforpredictingtheluminalfromnonluminaltypeinpatientswithbreastcarcinoma
AT yunlaiwang developmentandvalidationofanultrasoundbasedradiomicsnomogramforpredictingtheluminalfromnonluminaltypeinpatientswithbreastcarcinoma
AT liyanhu developmentandvalidationofanultrasoundbasedradiomicsnomogramforpredictingtheluminalfromnonluminaltypeinpatientswithbreastcarcinoma
AT dongxu developmentandvalidationofanultrasoundbasedradiomicsnomogramforpredictingtheluminalfromnonluminaltypeinpatientswithbreastcarcinoma
AT dongxu developmentandvalidationofanultrasoundbasedradiomicsnomogramforpredictingtheluminalfromnonluminaltypeinpatientswithbreastcarcinoma
AT zhengpingwang developmentandvalidationofanultrasoundbasedradiomicsnomogramforpredictingtheluminalfromnonluminaltypeinpatientswithbreastcarcinoma